These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 16078861)
41. [Molecular mechanism of carcinogenesis]. Shibuya M Gan To Kagaku Ryoho; 1993 Apr; 20(5):677-83. PubMed ID: 8470929 [TBL] [Abstract][Full Text] [Related]
42. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit? Felsher DW Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131 [TBL] [Abstract][Full Text] [Related]
43. MicroRNAs as novel targets and tools in cancer therapy. Abba ML; Patil N; Leupold JH; Moniuszko M; Utikal J; Niklinski J; Allgayer H Cancer Lett; 2017 Feb; 387():84-94. PubMed ID: 27045478 [TBL] [Abstract][Full Text] [Related]
44. Oncogene addiction: role of signal attenuation. Hübner A; Jaeschke A; Davis RJ Dev Cell; 2006 Dec; 11(6):752-4. PubMed ID: 17141149 [TBL] [Abstract][Full Text] [Related]
45. The multifaceted role of Notch in cancer. Roy M; Pear WS; Aster JC Curr Opin Genet Dev; 2007 Feb; 17(1):52-9. PubMed ID: 17178457 [TBL] [Abstract][Full Text] [Related]
46. Uncoupling the Oncogenic Engine. Schambach A; Schott JW; Morgan MA Cancer Res; 2017 Nov; 77(22):6060-6064. PubMed ID: 29097608 [TBL] [Abstract][Full Text] [Related]
47. New cancer genes crowd the horizon, create possibilities. Holzman D J Natl Cancer Inst; 1995 Aug; 87(15):1108-10. PubMed ID: 7674313 [No Abstract] [Full Text] [Related]
48. Oncogenes: a review of their clinical application. Demczuk S Crit Rev Oncol Hematol; 1991 Sep; 11(3):209-39. PubMed ID: 1958312 [TBL] [Abstract][Full Text] [Related]
49. MicroRNA-based therapeutics for cancer. Wang V; Wu W BioDrugs; 2009; 23(1):15-23. PubMed ID: 19344188 [TBL] [Abstract][Full Text] [Related]
53. [Significance of oncogenes and growth factors in hypernephroma]. Peter S Urologe A; 1992 Jan; 31(1):24-7. PubMed ID: 1553800 [TBL] [Abstract][Full Text] [Related]
54. Apoptosis and its clinical impact. Gastman BR Head Neck; 2001 May; 23(5):409-25. PubMed ID: 11295816 [TBL] [Abstract][Full Text] [Related]
55. DNA repair at the level of the gene: molecular and clinical considerations. Bohr VA J Cancer Res Clin Oncol; 1990; 116(4):384-91. PubMed ID: 2202730 [TBL] [Abstract][Full Text] [Related]
56. [From oncogenes to molecular biology of cancer and prevention of angiogenesis]. Alitalo K Duodecim; 1998; 114(24):2545-53. PubMed ID: 11757126 [No Abstract] [Full Text] [Related]
57. Growth factors and cancer. Aaronson SA Science; 1991 Nov; 254(5035):1146-53. PubMed ID: 1659742 [TBL] [Abstract][Full Text] [Related]
58. Molecular pathways: comparing the effects of drugs and T cells to effectively target oncogenes. Anders K; Blankenstein T Clin Cancer Res; 2013 Jan; 19(2):320-6. PubMed ID: 23197254 [TBL] [Abstract][Full Text] [Related]
59. MicroRNAs as therapeutic targets and their potential applications in cancer therapy. Cho WC Expert Opin Ther Targets; 2012 Aug; 16(8):747-59. PubMed ID: 22690697 [TBL] [Abstract][Full Text] [Related]
60. New molecular targets for cancer therapy. Oliff A; Gibbs JB; McCormick F Sci Am; 1996 Sep; 275(3):144-9. PubMed ID: 8701284 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]